[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-339586-en":3,"detail-sidebar-cat-0-en-105":51,"doc-seo-339586-105":99},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30,"preview_page_count":31,"preview_urls":32},339586,5909877438554,"Maeve","https://ap-avatar.wpscdn.com/avatar/5600025385ad2bf12a7?_k=1778553567797529272",8,"Research & Report","Arterial Thrombosis in Patients with Cancer - Review","Patients with cancer face elevated risk of arterial thromboembolic disease because common drivers of cancer development, the cancer itself, and anticancer treatments converge on arterial thrombosis mechanisms. This review synthesizes the epidemiology and pathophysiology of arterial thromboembolism in cancer patients and summarizes prevention and treatment strategies across relevant clinical contexts. It also presents a generalized management approach tailored to this patient population.","cancers   \nReview  \nArterial Thrombosis in Patients with Cancer  \nYan Xu , Marc Carrier * and Miriam Kimpton  \nCitation: Xu, Y.; Carrier, M.; Kimpton, M. Arterial Thrombosis in Patients with Cancer. Cancers 2024, 16, 2238 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)cancers16122238  \nAcademic Editor: Mingyi Chen  \nReceived: 25 April 2024  \nRevised: 3 June 2024  \nAccepted: 13 June 2024  \nPublished: 17 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nDepartment of Medicine, The Ottawa Hospital Research Institute at University of Ottawa, Ottawa, ON K1H 8L6,  \nCanada; [yaxu@toh.ca](yaxu@toh.ca) (Y.X.); [mkimpton@ohri.ca](mkimpton@ohri.ca) (M.K.)  \n* Correspondence: mcarrier@toh.ca; Tel.: +1-613-737-8899 (ext. 73034); Fax: +1-613-737-8861  \nSimple Summary: Patients with cancer are at high risk of blood clots in the arteries, leading to complications, such as stroke and heart attack. In this review, we discuss the risk factors associated with arterial blood clots in cancer patients, provide explanations on the cause of the arterial blood clots, and report on the current strategies for the prevention and treatment of arterial blood clots in cancer patients.  \nAbstract: Patients with cancer are at increased risk of arterial thromboembolic disease due to the presence of risk factors common to both the development of cancer and arterial thrombosis, the cancer itself, and the treatments provided to treat cancer. We review here the epidemiology and pathophysiology of arterial thromboembolic disease in cancer, along with its prevention and treatment strategies. We also propose a generalized approach for the management of arterial thromboembolic disease in this patient population.  \nKeywords: embolism and thrombosis; arteries; neoplasms  \n1. Introduction  \n1.1. Case 1  \nA 75-year-old woman with stage IIIB non-small lung cancer is referred for assessment of antithrombotic therapy in the context of a cerebellar infarct. The patient had nonresectable disease at diagnosis but had not yet started systemic therapy. Upon presentation to the ED with transient hemiparesis, dysphasia, and vertigo, a brain and neck computed tomogram with and without angiography queried the presence of cerebellar hypodensity, subsequently confirmed on magnetic resonance imaging to be early subacute infarcts in the left cerebellar hemisphere, right cerebellar hemisphere, and the right pons. No large vessel occlusion is noted. Workup demonstrates no features of shunt, mass, or non-bacterial thrombotic endocarditis with normal left atrial size. Holter monitoring for 72 h did not detect the presence of atrial tachyarrhythmia. Her 10-year global risk of cardiovascular disease based on the Framingham 2008 calculator was 11.7% .  \n1.2. Case 2  \nA 68-year-old man with polycythemia vera presents to the emergency department with chest pain. His current medications include low-dose aspirin, hydroxyurea, atorvastatin, and perindopril. He does not require regular phlebotomies for the management of polycythemia vera. Vital signs show a blood pressure of 93/72, HR 61, and oxygen saturation of 92% on 2 L by nasal prongs. Laboratory investigations reveal a hemoglobin of 142 g/L, platelets of 436 × 109/L, WBC of 12.3 × 109/L, and creatinine of 89 µmol/L. Troponin is elevated. ECG is diagnostic for an ST-elevation myocardial infarction. The patient is started on aspirin and intravenous unfractionated heparin. Cardiology is consulted.  \nCancers 2024, 16, 2238. [https://doi.org/10.3390/cancers16122238](https://doi.org/10.3390/cancers16122238) [https://www.mdpi.com/journal/cancers](https://www.mdpi.com/journal/cancers)  \n2. Epidemiology","cbCaigp0giD7KfJh","https://ap.wps.com/l/cbCaigp0giD7KfJh","pdf",305080,6,1,17,"English","en",105,"# Introduction\n## Case 1\n## Case 2\n# Epidemiology of Arterial Thrombosis in Cancer\n## Overall Incidence","[{\"question\":\"Why are patients with cancer at increased risk of arterial thromboembolic disease?\",\"answer\":\"The review attributes the increased risk to risk factors shared by cancer development and arterial thrombosis, plus effects from the cancer itself and anticancer treatments.\"},{\"question\":\"What does the document cover regarding arterial thromboembolism in cancer patients?\",\"answer\":\"It reviews epidemiology and pathophysiology, then summarizes prevention and treatment strategies, including a generalized management approach.\"},{\"question\":\"What comparative incidence data are discussed for arterial events around cancer diagnosis?\",\"answer\":\"The review describes higher incidence of myocardial infarction and ischemic stroke within six months of a confirmed cancer diagnosis compared with matched non-cancer controls, using SEER–Medicare and Danish registry analyses.\"}]","Arterial Thrombosis in Patients with Cancer - Review | PDF",1790031127,43,4,[33,37,42,47],{"page_no":21,"url":34,"width":35,"height":36},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/662783879ca91a7b26ff9ce85d9fb06d.webp",983,1390,{"page_no":38,"url":39,"width":40,"height":41},2,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d6287fb7068e1cf5d40b1ab79f92de7.webp",982,1388,{"page_no":43,"url":44,"width":45,"height":46},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/290ba1550dd3a969fcbb19503ea27667.webp",981,1387,{"page_no":31,"url":48,"width":49,"height":50},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2dae021c2f1d856cc3c6ea6ff49c5eb8.webp",980,1385,{"code":4,"msg":5,"data":52},[53,58,62,66,71,75,80,83,88,91,95],{"id":21,"doc_module":4,"doc_module_name":54,"category_name":55,"show_sort_weight":56,"slug":57},"Document","Story & Novel",90,"story-novel",{"id":38,"doc_module":4,"doc_module_name":54,"category_name":59,"show_sort_weight":60,"slug":61},"Literature",80,"literature",{"id":31,"doc_module":4,"doc_module_name":54,"category_name":63,"show_sort_weight":64,"slug":65},"Exam",70,"exam",{"id":67,"doc_module":4,"doc_module_name":54,"category_name":68,"show_sort_weight":69,"slug":70},5,"Comic",60,"comic",{"id":20,"doc_module":4,"doc_module_name":54,"category_name":72,"show_sort_weight":73,"slug":74},"Technology",50,"technology",{"id":76,"doc_module":4,"doc_module_name":54,"category_name":77,"show_sort_weight":78,"slug":79},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":54,"category_name":12,"show_sort_weight":81,"slug":82},30,"research-report",{"id":84,"doc_module":4,"doc_module_name":54,"category_name":85,"show_sort_weight":86,"slug":87},9,"Religion & Spirituality",20,"religion-spirituality",{"id":86,"doc_module":4,"doc_module_name":54,"category_name":89,"show_sort_weight":86,"slug":90},"World Cup","world-cup",{"id":92,"doc_module":4,"doc_module_name":54,"category_name":93,"show_sort_weight":92,"slug":94},10,"Lifestyle","lifestyle",{"id":96,"doc_module":4,"doc_module_name":54,"category_name":97,"show_sort_weight":67,"slug":98},19,"General","general",{"code":4,"msg":100,"data":101},"ok",{"site_id":25,"language":24,"slug":102,"title":13,"keywords":103,"description":14,"schema_data":104,"social_meta":157,"head_meta":159,"extra_data":161,"updated_unix":162},"arterial-thrombosis-in-patients-with-cancer-review","",{"@graph":105,"@context":156},[106,119,139],{"@type":107,"itemListElement":108},"BreadcrumbList",[109,113,115,117],{"item":110,"name":111,"@type":112,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":114,"name":54,"@type":112,"position":38},"https://docshare.wps.com/document/",{"item":116,"name":12,"@type":112,"position":43},"https://docshare.wps.com/document/research-report/",{"item":118,"name":13,"@type":112,"position":31},"https://docshare.wps.com/document/arterial-thrombosis-in-patients-with-cancer-review/339586/",{"url":118,"name":13,"@type":120,"image":121,"author":126,"headline":13,"publisher":128,"fileFormat":131,"inLanguage":24,"description":14,"dateModified":132,"datePublished":133,"encodingFormat":131,"isAccessibleForFree":134,"interactionStatistic":135},"DigitalDocument",{"url":122,"@type":123,"width":124,"height":125},"https://docshare.wps.com/thumbnails/arterial-thrombosis-in-patients-with-cancer-review/339586.png","ImageObject",300,407,{"name":9,"@type":127},"Person",{"url":110,"name":129,"@type":130},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":136,"interactionType":137,"userInteractionCount":20},"InteractionCounter",{"@type":138},"ViewAction",{"@type":140,"mainEntity":141},"FAQPage",[142,148,152],{"name":143,"@type":144,"acceptedAnswer":145},"Why are patients with cancer at increased risk of arterial thromboembolic disease?","Question",{"text":146,"@type":147},"The review attributes the increased risk to risk factors shared by cancer development and arterial thrombosis, plus effects from the cancer itself and anticancer treatments.","Answer",{"name":149,"@type":144,"acceptedAnswer":150},"What does the document cover regarding arterial thromboembolism in cancer patients?",{"text":151,"@type":147},"It reviews epidemiology and pathophysiology, then summarizes prevention and treatment strategies, including a generalized management approach.",{"name":153,"@type":144,"acceptedAnswer":154},"What comparative incidence data are discussed for arterial events around cancer diagnosis?",{"text":155,"@type":147},"The review describes higher incidence of myocardial infarction and ischemic stroke within six months of a confirmed cancer diagnosis compared with matched non-cancer controls, using SEER–Medicare and Danish registry analyses.","https://schema.org",{"og:url":118,"og:type":158,"og:title":13,"og:site_name":129,"og:description":14},"article",{"robots":160,"canonical":118},"index,follow",{"doc_id":7,"site_id":25},1790161847]